Natixis Advisors LLC Has $12.30 Million Holdings in Axon Enterprise, Inc $AXON

Natixis Advisors LLC cut its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 23.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 21,659 shares of the biotechnology company’s stock after selling 6,716 shares during the period. Natixis Advisors LLC’s holdings in Axon Enterprise were worth $12,301,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise in the third quarter valued at approximately $29,000. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $37,000. Creative Financial Designs Inc. ADV acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $28,000. Sound Income Strategies LLC raised its holdings in shares of Axon Enterprise by 550.0% in the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock valued at $30,000 after purchasing an additional 44 shares during the last quarter. Finally, Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise in the fourth quarter valued at approximately $30,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Axon Enterprise Stock Down 5.3%

AXON stock opened at $486.12 on Friday. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49. The business has a 50 day moving average price of $408.04 and a two-hundred day moving average price of $491.92. The company has a market cap of $39.18 billion, a price-to-earnings ratio of 195.23, a P/E/G ratio of 8.84 and a beta of 1.45. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.01. The business had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.91 million. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm’s revenue was up 33.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.47 EPS. Analysts anticipate that Axon Enterprise, Inc will post 1.82 EPS for the current fiscal year.

Analysts Set New Price Targets

AXON has been the topic of a number of recent research reports. Wall Street Zen upgraded shares of Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Weiss Ratings upgraded Axon Enterprise from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, May 8th. Royal Bank Of Canada decreased their price target on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a research note on Wednesday, February 25th. Needham & Company LLC decreased their price target on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a research note on Friday, February 20th. Finally, JPMorgan Chase & Co. raised their price target on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $712.75.

Insiders Place Their Bets

In related news, Director Jeri Williams sold 629 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $469.64, for a total transaction of $295,403.56. Following the transaction, the director directly owned 1,141 shares of the company’s stock, valued at approximately $535,859.24. The trade was a 35.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Erika Nardini sold 198 shares of the business’s stock in a transaction that occurred on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the transaction, the director directly owned 1,946 shares in the company, valued at $985,804.68. The trade was a 9.24% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 3,548 shares of company stock valued at $1,542,775 over the last 90 days. 4.20% of the stock is owned by insiders.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon’s real-time translation technology was rolled out at the Calgary Police Service, a reminder that the company continues to win new public-safety deployments and expand its international footprint. Axon real-time translation rolls out at Calgary Police Service in Canadian debut
• Positive Sentiment: Recent earnings momentum remains a support for the stock, with Axon trading well above its post-earnings level and analysts still watching for continued growth after another strong quarterly report. Axon (AXON) Up 20.2% Since Last Earnings Report: Can It Continue?
• Neutral Sentiment: Analyst commentary on Axon was included in a broader industrial-goods roundup, but the headline did not indicate a major new catalyst for the stock. Analysts Offer Insights on Industrial Goods Companies: United Rentals (URI), ArcBest (ARCB) and Axon Enterprise (AXON)
• Neutral Sentiment: Insider-trading coverage highlighted recent Axon insider activity, which can attract attention but does not by itself confirm a change in fundamentals. Diamondback, Seagate, ZIM, Credo, Axon Insider Shakeup
• Negative Sentiment: Jim Cramer said Axon trades at a very high earnings multiple, reinforcing investor concerns that the stock’s valuation may be stretched. Jim Cramer on Axon: “It Sells at a Very High Price to Earnings Multiple”
• Negative Sentiment: Motorola’s $1.5 billion D-Fend acquisition revived competition concerns in public safety technology, potentially increasing pressure on Axon’s market share and long-term growth narrative. Motorola’s $1.5 Billion D-Fend Acquisition Reignites Its Direct Competition with Axon Enterprises

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.